Literature DB >> 7848310

Acceleration of experimental lapine osteoarthritis by calcium pyrophosphate microcrystalline synovitis.

A G Fam1, I Morava-Protzner, C Purcell, B D Young, P S Bunting, A J Lewis.   

Abstract

OBJECTIVE: To investigate the effects of chronic calcium pyrophosphate dihydrate (CPPD) synovitis on the development of osteoarthritic (OA) lesions in an animal model.
METHODS: OA was induced in the right knees of 30 male New Zealand white rabbits by partial lateral meniscectomy and section of the fibular collateral and sesamoid ligaments (PLM/LS), followed by 8 weekly intraarticular (IA) injections of 1 mg (low-dose) or 10 mg (high-dose) of CPPD crystals in 3 sets of experiments (10 rabbits each). The contralateral left knees served as controls: experiment 1 PLM/LS alone, experiment 2 8 weekly IA injections of CPPD crystals alone, and experiment 3 sham surgery plus 8 weekly IA injections of CPPD crystals.
RESULTS: At 8 weeks, repeated IA injections of low-dose and high-dose CPPD crystals into meniscectomized right knees resulted in more severe OA than in meniscectomized but noninjected left knees (experiment 1) (P = 0.003 and P = 0.001, respectively). One-fourth of the meniscectomized knees (11 of 40), both CPPD-injected and noninjected, showed embedded synovial cartilage shards.
CONCLUSION: The data demonstrate a worsening effect of chronic CPPD crystal-induced synovitis on experimental OA produced in the rabbit knees by PLM/LS, and support a possible role for CPPD microcrystalline inflammation in the progression of OA lesions in clinical CPPD crystal deposition disease.

Entities:  

Mesh:

Year:  1995        PMID: 7848310     DOI: 10.1002/art.1780380208

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  Chondrocalcinosis, osteophytes and osteoarthritis.

Authors:  K D Brandt
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

Review 2.  Calcium-Containing Crystals and Osteoarthritis: an Unhealthy Alliance.

Authors:  Richard Conway; Geraldine M McCarthy
Journal:  Curr Rheumatol Rep       Date:  2018-03-08       Impact factor: 4.592

Review 3.  The role of uric acid and other crystals in osteoarthritis.

Authors:  Johannes Nowatzky; Rennie Howard; Michael H Pillinger; Svetlana Krasnokutsky
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

4.  Treatment and management of pseudogout: insights for the clinician.

Authors:  Paul Macmullan; Geraldine McCarthy
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

Review 5.  Pathophysiology of articular chondrocalcinosis--role of ANKH.

Authors:  Abhishek Abhishek; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2010-11-23       Impact factor: 20.543

6.  Association of Chondrocalcinosis in Knee Joints With Pain and Synovitis: Data From the Osteoarthritis Initiative.

Authors:  Bobby Kwanghoon Han; Woojin Kim; Jingbo Niu; Shristi Basnyat; Veniamin Barshay; John P Gaughan; Charlene Williams; Sharon L Kolasinski; David T Felson
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-09-21       Impact factor: 4.794

Review 7.  Crystal deposition and osteoarthritis.

Authors:  N Olmez; H R Schumacher
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

Review 8.  Calcium-containing crystals and osteoarthritis: implications for the clinician.

Authors:  Christopher W Wu; Robert Terkeltaub; Kenneth C Kalunian
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

9.  Point: Hydroxyapatite crystal deposition is intimately involved in the pathogenesis and progression of human osteoarthritis.

Authors:  Geraldine M McCarthy; Herman S Cheung
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

10.  Pathogenic role of basic calcium phosphate crystals in destructive arthropathies.

Authors:  Hang-Korng Ea; Véronique Chobaz; Christelle Nguyen; Sonia Nasi; Peter van Lent; Michel Daudon; Arnaud Dessombz; Dominique Bazin; Geraldine McCarthy; Brigitte Jolles-Haeberli; Annette Ives; Daniel Van Linthoudt; Alexander So; Frédéric Lioté; Nathalie Busso
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.